Flucelvax Injection, Suspension
Product Images NDC 70461-655

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Flucelvax (NDC 70461-655). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Seqirus Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel – 0.5 mL Carton Label (Flu2t 0004 01)

Principal Display Panel – 0.5 mL Carton Label (Flu2t 0004 01)
This is a description of an influenza vaccine called FLUCELVAX. The vaccine is recommended for individuals 6 months of age and older and is administered intramuscularly. It contains specific strains of the influenza virus and is prepared from virus propagated in Madin Darby Canine Kidney (MDCK) cells. The manufacturing process involves inactivation with beta-propiolactone (BPL) and the use of materials such as polysorbate 80, cetyltrimethylammonium bromide (CTAB), and beta-propiolactone. The vaccine does not contain preservatives and should be stored between 2-8°C. The product is manufactured by Seqirus Inc. in Holly Springs, NC, and distributed by Seqirus USA Inc. in Summit, NJ, USA.*
FDA Label Image

Principal Display Panel – 0.5 mL Syringe Label (Flu2t 0004 02)

Principal Display Panel – 0.5 mL Syringe Label (Flu2t 0004 02)
This is a description of an influenza vaccine called FLUCELVAX® with the 2024-2025 formula. It is in a 0.5 mL dose for use in individuals aged 6 months and older. Manufactured by Seqirus Inc. with US License No. 2049, the product has the NDC code 70461-654-04.*
FDA Label Image

Principal Display Panel – 5 mL Carton Label (Flu2t 0004 03)

Principal Display Panel – 5 mL Carton Label (Flu2t 0004 03)
FDA Label Image

Principal Display Panel – 0.5 mL Vial Label (Flu2t 0004 04)

Principal Display Panel – 0.5 mL Vial Label (Flu2t 0004 04)
This is a description of an Influenza Vaccine in a multi-dose vial for use in persons 6 months of age and older. The vaccine should be stored between 2 — 8°C (36 — 46°F) and should not be frozen. It has a dose of 0.5 mL and the 2024 - 2025 formula. The vaccine is manufactured by Segirus Inc. in Holly Springs, NC and distributed by Seqirus USA Inc. in Summit, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.